Showing 7001-7010 of 19322 results for "".
Data Driving Preferred Guideline Recommendations in First-Line Therapy for Metastatic Melanoma
https://reachmd.com/programs/cme/data-driving-preferred-guideline-recommendations-in-first-line-therapy-for-metastatic-melanoma/36327/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Caring for Women with MS: Key Considerations for Pregnancy and Menopause
https://reachmd.com/programs/neurofrontiers/caring-for-women-with-ms-key-considerations-for-pregnancy-and-menopause/32368/Read about unique challenges for women with multiple sclerosis and key considerations for pregnant and menopausal patients.Exploring COPD Exacerbations Through the Lens of a Patient Case
https://reachmd.com/programs/deep-breaths-updates-chest/exploring-copd-exacerbations-through-the-lens-of-a-patient-case/14162/Learn more about the pathophysiology behind COPD exacerbations and the factors that may put our patients at risk.Therapies & Vaccines on the Horizon for COVID-19
https://reachmd.com/programs/the-drug-report/therapies-vaccines-on-the-horizon-for-covid-19/11288/After much research activity has been devoted to finding a vaccine and cure for COVID-19, could there finally be hope amid this global pandemic?A Deep Dive into the Management of AEs Associated with ADCs
https://reachmd.com/programs/cme/a-deep-dive-into-the-management-of-aes-associated-with-adcs/13767/Rapid-fire approvals of ADCs for a variety of solid tumors now present a clinical conundrum when managing adverse events. Brush up on your knowledge!Community Clinic: Translating Data Into Action ─ Practical Strategies for Optimizing First-Line RCC Management
https://reachmd.com/programs/cme/Community-Clinic-Translating-Data-Into-Action-Practical-Strategies-for-Optimizing-First-Line-RCC-Management/35774/Learn to apply evidence-based strategies to guide first-line therapy selection and manage treatment-related adverse events in advanced renal cell carcinomaThe NASH Epidemic: Highlights from the AMCP 2023 Symposium
https://reachmd.com/programs/cme/the-nash-epidemic-highlights-from-the-amcp-2023-symposium/14957/Tune in to hear key takeaways and a breakdown of clinical data from a recent satellite symposium focused on the screening and treatment NASH.SunRISe-1: 1-Year Durability and Patient-Reported Outcomes Results
https://reachmd.com/clinical-practice/oncology-hematology/sunrise-1-1-year-durability-and-patient-reported-outcomes-results/33075/Dr. Neal Shore discusses new data presented at AUA 2025 from SunRISe-1 on TAR-200 monotherapy in patients with BCG-unresponsive high-risk NMIBC CIS.Surgical Evaluation and Treatment for Genetic Epilepsies
https://reachmd.com/diseases-diagnoses/epilepsy-seizures/surgical-evaluation-and-treatment-for-genetic-epilepsies/32053/Genetic diagnosis can be useful in guiding surgical options for genetic epilepsies.Optimizing the Care and Quality of Life for Patients with ADPKD – Part 3: Management
https://reachmd.com/programs/cme/optimizing-the-care-and-quality-of-life-for-patients-with-adpkd-part-3-management/12679/Once a patient is diagnosed with autosomal dominant polycystic kidney disease, how can we manage them?